IGC Pharma Inc (AMEX:IGC) traded at $0.38 at close of the session on Friday, July 11 and made a downward move of -8.24% on its previous day’s price.
Looking at the stock we see that its previous close was $0.41 and the beta (5Y monthly) reads 1.479 with the day’s price range being $0.37 – $0.395. In terms of its 52-week price range, IGC has a high of $0.50 and a low of $0.25. The company’s stock has gained about 23.16% over that past 30 days.
IGC Pharma Inc has a market cap of $31.95 million and is expected to release its quarterly earnings report on 2025-Jun-27.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 326k, with a low of 326k and a high of 326k. The median projection represents growth squeezing down to 19.85% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 1.45M, or 14.12% up from figures reported last year.
On the other hand, looking at the outlook for the IGC stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the IGC Pharma Inc (IGC) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 19.64% off its SMA20 and 21.85% from its 50-day simple moving average. The RSI (14) is pointing at 67.89 while the volatility over the past week is 15.13% and jumps to 6.37% over the past one month.
Coming back to IGC Pharma Inc (AMEX:IGC), we note that the average 3-month trading volume was 2.24 million, while that of the preceding 10-day period stands at 13.26 million. Current shares outstanding are 80.88 million.
The insiders hold 31.76% of the company’s shares while institutions hold 3.41%. The data shows that short shares as of 2025-06-13, stood at 0.53 million at a short ratio of 2.25. This represents a 96.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 0.65 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -11.65% down in year-to-date price movement.
